Green Urine after Intragastric Balloon Placement for the Treatment of Morbid Obesity

被引:0
|
作者
Paolo Bernante
Francesco Francini
Fabio Zangrandi
Paola Menegon
Antonio Toniato
Paolo Feltracco
Maria Rosa Pelizzo
机构
来源
Obesity Surgery | 2003年 / 13卷
关键词
GREEN URINE; PROPOFOL; INTRAGASTRIC BALLOON; MORBID OBESITY; OBESITY; DRUG SIDE-EFFECT;
D O I
暂无
中图分类号
学科分类号
摘要
Background: The intragastric balloon is filled with saline and methylene blue dye, to detect balloon deflation early and prevent bowel obstruction, by monitoring the patient's urine for changes in color. Methods: An intragastric balloon filled with 590 ml of saline plus 10 ml of methylene blue was endoscopically placed under sedation in a 22-year-old man with morbid obesity (BMI 42 kg/m2). 3 days later, the patient's urine changed to dark green, and, suspecting a leaking balloon, endoscopy was repeated under sedation. Results: No signs of balloon deflation were seen, and the urine returned to normal color. The next day, the urine turned green again. 7 days later, the urine discoloration finally disappeared. Conclusion: Propofol, a sedative commonly used by anesthesiologists during endoscopic procedures, is known to have several side-effects, and urine discoloration is one of them, albeit rare. This benign side-effect must be known to obesity surgeons to avoid pointless medical expenditure, unnecessary balloon removal and distress for patients and clinicians.
引用
收藏
页码:951 / 953
页数:2
相关论文
共 50 条
  • [31] Intragastric balloon for morbid obesity causing chronic gastric dilatation
    Pretolesi, F
    Redaelli, G
    Papagni, L
    Derchi, LE
    EUROPEAN RADIOLOGY, 2001, 11 (04) : 588 - 589
  • [32] Intragastric balloon for management of morbid obesity in a candidate for heart transplantation
    Storm, Andrew C.
    Lakdawala, Neal K.
    Thompson, Christopher C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (07): : 820 - 821
  • [33] INTRAGASTRIC BALLOON FOR MORBID OBESITY: A RETROSPECTIVE EVALUATION OF EFFICACY AND TOLERANCE
    Ciardo, V.
    Zilli, M.
    Berretti, D.
    Macor, C.
    Maieron, R.
    Marino, M.
    Pevere, S.
    Rossitti, P.
    Zoratti, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S167 - S167
  • [34] Intragastric balloon placement in the treatment of overweight and obesity: Experience at a Mexican referral center
    Hernandez-Lara, A. H.
    Almazan-Urbina, F. E.
    Santiago-Torres, M.
    Rangel-Cruz, E.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2020, 85 (04): : 410 - 415
  • [35] Intragastric stimulation (IGS) for treatment of morbid obesity
    Miller, K
    Höller, E
    Hell, E
    ZENTRALBLATT FUR CHIRURGIE, 2002, 127 (12): : 1049 - 1053
  • [36] Adjustable intragastric balloon for treatment of obesity
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 117 - 117
  • [37] TREATMENT OF OBESITY BY INSTALLATION OF AN INTRAGASTRIC BALLOON
    BEERGABEL, M
    FENZY, A
    PUCHELLE, JC
    PRESSE MEDICALE, 1986, 15 (40): : 2020 - 2020
  • [38] THE INTRAGASTRIC BALLOON, A NEW TREATMENT FOR OBESITY
    DURRANS, D
    TAYLOR, TV
    CLINICAL NUTRITION, 1986, 5 : 113 - 115
  • [39] INTRAGASTRIC BALLOON IN TREATMENT OF EXCESSIVE OBESITY
    WILLMEN, HR
    SCHNEIDER, W
    LOFFLER, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (31-3) : 1200 - 1202
  • [40] BioEnterics Intragastric Balloon for Treatment of Morbid Obesity in Prader–Willi Syndrome: Specific Risks and Benefits
    F. De Peppo
    G. Di Giorgio
    M. Germani
    E. Ceriati
    P. Marchetti
    C. Galli
    M. G. Ubertini
    S. Spera
    G. Ferrante
    M. Cuttini
    M. Cappa
    G. Castelli Gattinara
    M. Rivosecchi
    A. Crinò
    Obesity Surgery, 2008, 18 : 1443 - 1449